Pregled bibliografske jedinice broj: 989823
Separation of active and inactive forms of human antithrombin by heparin affinity chromatography
Separation of active and inactive forms of human antithrombin by heparin affinity chromatography // Thrombosis Research, 106 (2002), 2; 157-164 doi:10.1016/s0049-3848(02)00097-x (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 989823 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Separation of active and inactive forms of human antithrombin by heparin affinity chromatography
Autori
Heger, Andrea ; Grunert, Tom ; Schulz, Petra ; Josic, Djuro ; Buchacher, Andrea
Izvornik
Thrombosis Research (0049-3848) 106
(2002), 2;
157-164
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Antithrombin Active and inactive isoforms Latent antithrombin Heparin affinity chromatography
Sažetak
During the manufacturing of an antithrombin preparation, it is necessary to define all steps that may damage or alter the target molecule, and thus decrease the biological activity of the inhibitor in blood coagulation. Pasteurization, commonly used procedure for viral inactivation of plasma derived antithrombin concentrates, was shown to partially alter the conformation of the active native antithrombin to an inactive latent form. To study intensively the different forms of inactive antithrombin that are formed upon heat treatment, human α-antithrombin, human β-antithrombin and an equimolar mixture of the two isoforms were incubated at 60 °C for 15 h in the presence of citrate as stabilizing agent. Using two subsequent heparin affinity chromatography steps, three different inactive fractions were separated. By comparison of the heparin binding capacities, isoelectric points and unfolding characteristics of these inactive forms, the α-latent and β-latent antithrombin isoforms could be identified. It was also shown that additional inactive forms such as proteinase cleaved and/or oxidized forms of antithrombin are formed during the heat treatment process. In four commercially available antithrombin preparations, all produced by pasteurization, the amount of inactive protein varied between 0.5% and 9.5%.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Sveučilište u Rijeci - Odjel za biotehnologiju
Profili:
Đuro Josić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE